{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:09:32Z","timestamp":1785802172077,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":79,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.biologicals.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T22:05:40Z","timestamp":1558649140000},"page":"1-7","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting"],"prefix":"10.1016","volume":"60","author":[{"given":"Kathryn","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germaine","family":"Hanquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jankosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nohynek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.05.005_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.biologicals.2016.04.007","article-title":"Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?","volume":"44","author":"Johansen","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.05.005_bib2","first-page":"453","article-title":"Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009","volume":"58","author":"Centers for Disease Control Prevention","year":"2009","journal-title":"MMWR Morbid Mortal Week Rep"},{"key":"10.1016\/j.biologicals.2019.05.005_bib3","unstructured":"World Health Organization. Pandemic (H1N1) 2009\u2014update 89. In: WHO, editor. Weekly update2010."},{"key":"10.1016\/j.biologicals.2019.05.005_bib4","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/j.vaccine.2010.03.072","article-title":"Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination","volume":"28","author":"Chlibek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib5","series-title":"Twenty-second pandemic pharmacovigilance update","year":"2010"},{"key":"10.1016\/j.biologicals.2019.05.005_bib6","series-title":"The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix","author":"Swedish Medical Products Agency (MPA)","year":"2010"},{"key":"10.1016\/j.biologicals.2019.05.005_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/joim.12391","article-title":"A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009\u20132010 Pandemrix vaccination programme in Sweden","volume":"278","author":"Feltelius","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.biologicals.2019.05.005_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.05.005_bib9","series-title":"National institute for health and Welfare recommends discontinuation of Pandemrix vaccinations","author":"Finnish National Institute for Health and Welfare website (THL)","year":"2010"},{"key":"10.1016\/j.biologicals.2019.05.005_bib10","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.biologicals.2019.05.005_bib11","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1016\/j.vaccine.2012.10.030","article-title":"No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study","volume":"30","author":"Choe","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib12","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.biologicals.2019.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.05.005_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sleep.2017.02.026","article-title":"Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany","volume":"34","author":"Oberle","year":"2017","journal-title":"Sleep Med"},{"key":"10.1016\/j.biologicals.2019.05.005_bib15","first-page":"15","article-title":"Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010","volume":"19","author":"O'Flanagan","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.biologicals.2019.05.005_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.vaccine.2017.02.053","article-title":"Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic","volume":"35","author":"Trogstad","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/00365548.2011.580777","article-title":"Explorations of clinical trials and pharmacovigilance databases of MF59(R)-adjuvanted influenza vaccines for associated cases of narcolepsy","volume":"43","author":"Tsai","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.biologicals.2019.05.005_bib18","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.vaccine.2012.12.015","article-title":"The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns","volume":"31","author":"Wijnans","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib19","doi-asserted-by":"crossref","first-page":"20064","DOI":"10.2807\/ese.17.04.20064-en","article-title":"Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe","volume":"17","author":"Mereckiene","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.biologicals.2019.05.005_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/1471-2334-13-435","article-title":"Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials","volume":"13","author":"Launay","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.biologicals.2019.05.005_bib21","series-title":"The 2009 H1N1 pandemic: summary highlights, April 2009-april 2010","author":"CDC","year":"2010"},{"key":"10.1016\/j.biologicals.2019.05.005_bib22","doi-asserted-by":"crossref","first-page":"19361","DOI":"10.2807\/ese.14.41.19361-en","article-title":"Pandemic influenza A(H1N1) 2009 vaccines in the European Union","volume":"14","author":"Johansen","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.biologicals.2019.05.005_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00063030-200822050-00001","article-title":"Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus","volume":"22","author":"Carter","year":"2008","journal-title":"BioDrugs: Clin. Immunotherapeut., Biopharmaceut. Gene Therapy"},{"key":"10.1016\/j.biologicals.2019.05.005_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2015.7916","article-title":"Effect of varying doses of a monovalent H7N9 influenza vaccine with and without AS03 and MF59 adjuvants on immune response: a randomized clinical trial","volume":"314","author":"Jackson","year":"2015","journal-title":"Jama"},{"key":"10.1016\/j.biologicals.2019.05.005_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2014.11.004","article-title":"Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development","volume":"47","author":"Jacob","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biologicals.2019.05.005_bib26","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1542\/peds.2010-1920","article-title":"Influenza A\/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months","volume":"127","author":"Esposito","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.biologicals.2019.05.005_bib27","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.vaccine.2017.02.059","article-title":"Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis","volume":"35","author":"Lansbury","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib28","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.vaccine.2015.04.011","article-title":"Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children","volume":"33","author":"\u00d6rtqvist","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2014.12.010","article-title":"HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy","volume":"96","author":"Ollila","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biologicals.2019.05.005_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.biologicals.2019.05.005_bib31","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.5665\/sleep.4066","article-title":"HLA DQB1*06:02 negative narcolepsy with hypocretin\/orexin deficiency","volume":"37","author":"Han","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.biologicals.2019.05.005_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003880","article-title":"Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic","volume":"9","author":"Han","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biologicals.2019.05.005_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.biologicals.2019.05.005_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068402","article-title":"No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland","volume":"8","author":"Melen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.05.005_bib35","doi-asserted-by":"crossref","first-page":"B6","DOI":"10.1016\/j.vaccine.2015.03.026","article-title":"The narcolepsy-pandemic influenza story: can the truth ever be unraveled?","volume":"33","author":"Sturkenboom","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib36","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.vaccine.2018.08.008","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - multi-country assessment","volume":"36","author":"Weibel","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.05.005_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2018.10.036","article-title":"Narcolepsy and 2009 H1N1 pandemic vaccination in Taiwan","author":"Huang","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.biologicals.2019.05.005_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.sleep.2013.12.012","article-title":"Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in eastern China","volume":"15","author":"Wu","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.biologicals.2019.05.005_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biologicals.2019.05.005_bib40","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.0000000000000987","article-title":"Vaccine Safety D. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States","volume":"83","author":"Duffy","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.biologicals.2019.05.005_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jsr.12567","article-title":"Narcolepsy with cataplexy and pregnancy: a case-control study","volume":"27","author":"Calvo-Ferrandiz","year":"2018","journal-title":"J Sleep Res"},{"key":"10.1016\/j.biologicals.2019.05.005_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/338014","article-title":"Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine","volume":"185","author":"Gelder","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2019.05.005_bib43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/irv.12074","article-title":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries","volume":"7","author":"Van Kerkhove","year":"2013","journal-title":"Influenza Other Respirat Viruses"},{"key":"10.1016\/j.biologicals.2019.05.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151575","article-title":"Twin peaks: A\/H1N1 pandemic influenza virus infection and vaccination in Norway","volume":"11","author":"Van Effelterre","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.05.005_bib45","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1073\/pnas.1521463112","article-title":"H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice","volume":"113","author":"Tesoriero","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2019.05.005_bib46","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2019.05.005_bib47","doi-asserted-by":"crossref","first-page":"294ra105","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biologicals.2019.05.005_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/hv.27412","article-title":"Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal","volume":"10","author":"van der Most","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2019.05.005_bib49","series-title":"Families affected by swine flu jab to demand action from EU health commissioner","author":"Hennessy","year":"2014"},{"key":"10.1016\/j.biologicals.2019.05.005_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLoS One"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619300478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105619300478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T15:10:39Z","timestamp":1663513839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105619300478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":50,"alternative-id":["S1045105619300478"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.05.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}